Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

valls-comamala2017_2528.pdf (2.37 MB)

Document type

Article

Version

Published version

Publication date

2017-04-13

Publication license

cc by (c) Valls Comamala et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/110867

The antigen-binding fragment of human gamma immunoglobulin prevents amyloid beta-peptide folding into beta-sheet to form oligomers

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.18632/oncotarget.17074

Abstract

The amyloid beta-peptide (Abeta) plays a leading role in Alzheimer's disease (AD) physiopathology. Even though monomeric forms of Abeta are harmless to cells, Abeta can aggregate into beta-sheet oligomers and fibrils, which are both neurotoxic. Therefore, one of the main therapeutic approaches to cure or delay AD onset and progression is targeting Abeta aggregation. In the present study, we show that a pool of human gamma immunoglobulins (IgG) protected cortical neurons from the challenge with Abeta oligomers, as assayed by MTT reduction, caspase-3 activation and cytoskeleton integrity. In addition, we report the inhibitory effect of IgG on Abeta aggregation, as shown by Thioflavin T assay, size exclusion chromatography and atomic force microscopy. Similar results were obtained with Palivizumab, a human anti-sincitial virus antibody. In order to dissect the important domains, we cleaved the pool of human IgG with papain to obtain Fab and Fc fragments. Using these cleaved fragments, we functionally identified Fab as the immunoglobulin fragment inhibiting Abeta aggregation, a result that was further confirmed by an in silico structural model. Interestingly, bioinformatic tools show a highly conserved structure able to bind amyloid in the Fab region. Overall, our data strongly support the inhibitory effect of human IgG on Abeta aggregation and its neuroprotective role.

Subject

Malaltia d'Alzheimer, Immunoglobulines, Malalties neurodegeneratives

Subject (English)

Alzheimer's disease, Immunoglobulins, Neurodegenerative Diseases

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

VALLS COMAMALA, Victòria, et al. The antigen-binding fragment of human gamma immunoglobulin
                prevents amyloid beta-peptide folding into beta-sheet to form
                oligomers. Oncotarget. 2017. Vol. 8, num. 25, pags. 41154-41165. ISSN 1949-2553. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/110867

Export metadata

JSON - METS

Share record